BrainStorm Cell Therapeutics
BCLI
#10688
Rank
โ‚ฌ8.48 M
Marketcap
0,77ย โ‚ฌ
Share price
1.03%
Change (1 day)
-23.65%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -โ‚ฌ9.77 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ10.16 Million, an increase over its 2023 earnings that were of -โ‚ฌ15.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ9.77 Million-3.87%
2024 -โ‚ฌ10.16 Million-32.39%
2023 -โ‚ฌ15.03 Million-29.18%
2022 -โ‚ฌ21.22 Million-0.74%
2021 -โ‚ฌ21.37 Million-23.12%
2020 -โ‚ฌ27.8 Million36.8%
2019 -โ‚ฌ20.32 Million66.71%
2018 -โ‚ฌ12.19 Million181.66%
2017 -โ‚ฌ4.33 Million-0.6%
2016 -โ‚ฌ4.36 Million-41.31%
2015 -โ‚ฌ7.42 Million-8.22%
2014 -โ‚ฌ8.08 Million89.74%
2013 -โ‚ฌ4.26 Million42.27%
2012 -โ‚ฌ3 Million-12.45%
2011 -โ‚ฌ3.42 Million63.04%
2010 -โ‚ฌ2.1 Million35.52%
2009 -โ‚ฌ1.55 Million-48.99%
2008 -โ‚ฌ3.04 Million-44.39%
2007 -โ‚ฌ5.46 Million
2005 -โ‚ฌ2.83 Million-91.44%
2004 -โ‚ฌ33.01 Million94007.62%
2003 -โ‚ฌ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
โ‚ฌ1.41 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.55 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚ฌ0.7 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.73 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ18.05 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚ฌ0.23 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA